The number of new graduates hired for sales rep roles increased in FY2025 after declining for five consecutive years, a…
HOME > BUSINESS
BUSINESS
- Azilva Ranked No. 1 for Third Consecutive Month in Both GP, HP Markets in July: Rep Track Survey
August 23, 2012
- Janssen Pharmaceutical Appoints Goodwin as Next President
August 23, 2012
- Inavir Significantly Prevents Influenza Infection in PIII: Daiichi Sankyo
August 23, 2012
- Eli Lilly Japan Not to File for Listing of Bydureon Due to Expected Rights Return
August 22, 2012
- Shionogi to Launch Quick Flu Diagnostic Kit on September 11
August 22, 2012
- Neoral, Sandimmune Approved for Small Intestine Transplantation: Novartis
August 22, 2012
- Eisai’s Halaven Receives Orphan Drug Designation for Soft-Tissue Sarcoma in US
August 22, 2012
- Pazopanib Approved for aSTS in Europe: GSK
August 22, 2012
- Oncology Japan 2012 to Be Held on November 7, 8
August 22, 2012
- Mediscience Stepping Up Athlete Recruitments as CMRs
August 21, 2012
- ARB Prescription Rate Affected by Doctors’ Evaluations of MRs: M3 Survey
August 21, 2012
- Generic Actos Launched in US; Takeda Grants AG to Teva, Ranbaxy
August 21, 2012
- Astellas to Build New Building to Boost Production Capacity of Investigational Anticancer Drug Substances
August 21, 2012
- DSP to Set Up Cancer Institute Led by CEO of Its US Subsidiary BBI
August 21, 2012
- Synagis IM Liquid Injection Solution Approved: Abbott Japan
August 20, 2012
- Pfizer Terminates Development of AD Treatment Bapineuzumab
August 20, 2012
- RIBOMIC Acquired Patent for Analgesic Agent Containing Aptamer
August 20, 2012
- “Sense of Achievement” Motivates MRs; Brach Managers to Be Blamed for Miscommunications: Survey of Managers
August 20, 2012
- OncoTherapy Confirms Safety of OCV-C01 for Pancreatic Cancer in PIII Trial
August 17, 2012
- Mizuho Forecasts Sales Increases and Falling Profits in FY2012 for 9 Major Domestic Pharmaceutical Manufacturers
August 17, 2012
ページ
The traditional HR Business Partner (HRBP) model, once the gold standard for HR delivery, is undergoing a significant transformation. Many organizations, particularly in industries like pharmaceuticals, are moving towards a more agile resource model, aiming to streamline HR operations and…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…